Compare Caprion Pharmaceuticals vs Sword Bio
Customers evaluate the quality of Caprion Pharmaceuticals's products using the following success metrics.
Overview
Caprion Pharmaceuticals is 26 yrs old and is based in Canada.
Caprion's leading and proteomics discovery technologies - CellCarta - enable the discovery of targets for therapeutics development and the identification of protein biomarkers that can reduce risk and enhance clinical development productivity and decision making in Pharmaceutical research. In March 2007, Caprion Pharmaceuticals merged with Ecopia BioSciences to form Thallion Pharmaceuticals.
Sword Bio is 20 yrs old and is based in United States.
Sword Bio develops a medical data research platform designed to determine and monitor the value of biological markers. The platform uses a technology involving resonance Raman to aid in the performance of the assays offering medical research, drug discovery, and the provision of healthcare products and services. It was formerly known as Sword Diagnostics. The company was founded in 2004 and is based in Chicago, Illinois.
Demo Video
Leadership
Clarissa Desjardins (Founder)
David Dingott (Chief Executive Officer)
Investors
Thallion Pharmaceuticals, Ventures West
Ellipsis Ventures, Turret Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Caprion Pharmaceuticals has not claimed their profile.
Work for Caprion Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Caprion Pharmaceuticals?
Claim your profile now.
Information not available because Sword Bio has not claimed their profile.
Work for Sword Bio? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Sword Bio?
Claim your profile now.